| Use of sirolimus-eluting stents for treatment of in-stent restenosis: long-term follow-up. | |
| | |
MedLine Citation:
|
PMID: 17700399 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: The aims of this study were to assess (i) the feasibility, safety and efficacy of sirolimus-eluting stents (SESs) in treating in-stent restenosis (ISR), (ii) the risk factors for recurrent ISR, and (iii) the long-term major adverse cardiac events (MACE). METHODS: Between May 2002 and April 2004, 100 consecutive patients with evidence of myocardial ischaemia and 112 ISRs in native coronary arteries were treated using SESs. We evaluated the rate of procedural and clinical success, the incidence of in-hospital and long-term MACE, the recurrence rate of ISR after 6-8 months, and the risk factors for recurrent ISR and follow-up MACE. RESULTS: Forty-five percent of the lesions were directly stented. After stent implantation, the minimal lumen diameter increased from 0.51 +/- 0.32 to 2.50 +/- 0.32 mm in the stents and to 2.30 +/- 0.35 mm in the lesions (acute gain 1.99 +/- 0.37 mm). The procedural success rate was 99%. The clinical success rate was 88%. MACE occurred in 2.0% of patients during hospitalisation and in 12.8% after a median follow-up of 15.1 months (interquartile range 8.4-19.7). The recurrence rate of ISR was 11.8% after a median follow-up of 7.7 months (interquartile range 7.4-8.4). The risk for recurrent ISR was significantly higher in patients with diabetes or hypertension, in those aged more than 65 years and in female patients, as well as in the lesions with a small minimal lumen diameter. Three-vessel disease and age were risk factors for MACE. CONCLUSIONS: This study confirms the feasibility, safety and effectiveness of using SESs to treat ISR, and identifies a risk profile for recurrent ISR and MACE. |
| | |
Authors:
|
Nedy Brambilla; Maurizio Ferrario; Alessandra Repetto; Ezio Bramucci; Luigi Angoli; Umberto Canosi; Roberta Rosso; Marco Ferlini; Catherine Klersy; Luigi Tavazzi |
Related Documents
:
|
7747679 - Predictors of restenosis after excimer laser coronary angioplasty. 11733629 - Independent predictors of restenosis after percutaneous coronary revascularization in h... 1414929 - Influence of vessel selection on the observed restenosis rate after endoluminal stentin... 9160119 - Restenosis: is there a pharmacologic fix in the pipeline? 17354579 - Possible predictors of target lesion revascularization after drug-eluting stent implant... 18442619 - Metabolic syndrome does not increase angiographic restenosis rates after drug-eluting s... 7967019 - "myocardial stunning"-like phenomenon during a crisis of pheochromocytoma. 313199 - Ventricular function and the native coronary circulation five years after myocardial re... 21503169 - Benefit of stem cells and skeletal myoblast cells in dilated cardiomyopathies. |
Publication Detail:
|
Type: Clinical Trial; Journal Article |
Journal Detail:
|
Title: Journal of cardiovascular medicine (Hagerstown, Md.) Volume: 8 ISSN: 1558-2027 ISO Abbreviation: J Cardiovasc Med (Hagerstown) Publication Date: 2007 Sep |
Date Detail:
|
Created Date: 2007-08-16 Completed Date: 2007-10-25 Revised Date: 2009-05-28 |
Medline Journal Info:
|
Nlm Unique ID: 101259752 Medline TA: J Cardiovasc Med (Hagerstown) Country: United States |
Other Details:
|
Languages: eng Pagination: 699-705 Citation Subset: IM |
Affiliation:
|
Cardiology Division, IRCCS Policlinico San Matteo, Piazzale Golgi 2, 27100 Pavia, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Coronary Restenosis
/
complications,
drug therapy* Drug Delivery Systems Feasibility Studies Female Follow-Up Studies Heart Diseases / etiology Humans Immunosuppressive Agents / administration & dosage* Male Middle Aged Risk Factors Sirolimus / administration & dosage* Stents Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Immunosuppressive Agents; 53123-88-9/Sirolimus |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cardiac magnetic resonance of healthy children and young adults with frequent premature ventricular ...
Next Document: Prevalence of conduction delay of the right atrium in patients with SSS: implications for pacing sit...